Abstract:Musculoskeletal injuries, including tendinopathies, present a significant clinical burden for aging populations. While the biological drivers of age-related declines in tendon function are poorly understood, it is well accepted that dysregulation of extracellular matrix (ECM) remodeling plays a role in chronic tendon degeneration. Senescent cells, which have been associated with multiple degenerative pathologies in musculoskeletal tissues, secrete a highly pro-inflammatory senescence-associated secretory phenotype (SASP) that has potential to promote ECM breakdown. However, the role of senescent cells in the dysregulation of tendon ECM homeostasis is largely unknown. To assess this directly, we developed an in vitro model of induced cellular senescence in murine tendon explants. This novel technique enables us to study the isolated interactions of senescent cells and their native ECM without interference from age-related systemic changes. We document multiple biomarkers of cellular senescence in induced tendon explants including cell cycle arrest, apoptosis resistance, and sustained inflammatory responses. We then utilize this in vitro senescence model to compare the ECM remodeling response of young, naturally aged, and induced-senescent tendons to an altered mechanical stimulus. We found that both senescence and aging independently led to alterations in ECM-related gene expression, reductions in protein synthesis, and tissue compositional changes. Furthermore, MMP activity was sustained, thus shifting the remodeling balance of aged and induced-senescent tissues towards degradation over production. Together, this demonstrates that cellular senescence plays a role in the altered mechano-response of aged tendons and likely contributes to poor clinical outcomes in aging populations.

Employing Extracellular Matrix-Based Tissue Engineering Strategies for Age-Dependent Tissue Degenerations

Impaired angiogenesis in ageing: the central role of the extracellular matrix

Aged Skeletal Muscle Retains the Ability to Remodel Extracellular Matrix for Degradation of Collagen Deposition after Muscle Injury

3D ECM-Based Scaffolds Boost Young Cell Secretome-Derived EV Rejuvenating Effects in Senescent Cells

Extracellular matrix regulation of fibroblast function: redefining our perspective on skin aging

Age-Related Changes in Extracellular Matrix

All the small things: Nanoscale matrix alterations in aging tissues

Synergistic Effect of miR-200 and Young Extracellular Matrix-based Bio-scaffolds to Reduce Signs of Aging in Senescent Fibroblasts

Integrated-omics profiling unveils the disparities of host defense to ECM scaffolds during wound healing in aged individuals

Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases

Extracellular matrix-based materials for regenerative medicine

Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion

Aging, exercise, and extracellular matrix in the heart

Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering

Cellular senescence impairs tendon extracellular matrix remodeling in response to mechanical unloading

Strengths and opportunities in research into extracellular matrix ageing: A consultation with the ECMage research community

Degenerative tendon matrix induces tenogenic differentiation of mesenchymal stem cells

Rescuing Replication and Osteogenesis of Aged Mesenchymal Stem Cells by Exposure to a Young Extracellular Matrix.

Muscle tissue engineering and regeneration through epigenetic reprogramming and scaffold manipulation

Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing

Skin aging from the perspective of dermal fibroblasts: the interplay between the adaptation to the extracellular matrix microenvironment and cell autonomous processes